Healthcare & Pharma

In phase 1 clinical trials, Tykerb proved so beneficial to participants that the FDA put the drug on fast track for approval. We had to find a way to tell oncologists and patients with late stage HER 2+ metastatic breast cancer why another drug would make their last year of life better, longer, and worth trying another medication. And we had to tell them, without telling them.

Consumer & B2B

Cras justo odio, dapibus ac facilisis in, egestas eget quam. Etiam porta sem malesuada magna mollis euismod. Integer posuere erat a ante venenatis dapibus posuere velit aliquet. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum. Aenean eu leo quam. Pellentesque ornare sem lacinia quam venenatis vestibulum.

Digital & Broadcast

Maecenas sed diam eget risus varius blandit sit amet non magna. Curabitur blandit tempus porttitor. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec ullamcorper nulla non metus auctor fringilla. Aenean lacinia bibendum nulla sed consectetur. Nullam id dolor id nibh ultricies vehicula ut id elit. Curabitur blandit tempus porttitor.